D-Wave Quantum Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) covers events occurring between May 29, 2025, and June 3, 2025, with the report filed on June 4, 2025. D-Wave Quantum Inc., an emerging growth company incorporated in Delaware, reported significant capital inflows resulting from the exercise of warrants assumed during its 2022 merger with DPCM Capital, Inc.
Key Financial Metrics
The filing details proceeds from warrant exercises but does not provide comprehensive financial statements, revenue, profit, or debt metrics for the period.
- Total Warrant Proceeds (May 29 - June 3, 2025): Approximately $95.8 million.
- May 29, 2025 Exercise: Approximately $80.5 million from the exercise of ~7.0 million warrants.
- May 30 - June 3, 2025 Exercise: Approximately $15.3 million from the exercise of ~1.33 million warrants.
- Exercise Price: $11.50 per warrant.
- Warrant Terms: Each whole warrant is exercisable for 1.4541326 shares of common stock.
Material Changes
The primary material change is the substantial increase in cash liquidity due to the aggregate exercise of approximately 8.33 million warrants. This represents a significant capital event compared to the prior period, though the filing does not explicitly quantify the change in total cash balances or debt levels.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the warrant exercise mechanics. The proceeds were generated from warrants assumed in the August 5, 2022 merger.
Investor Verification Checklist
- Verify the total number of shares issued upon exercise (warrants convert at a ratio of 1.4541326 shares per warrant).
- Confirm the impact of the ~$95.8 million cash inflow on the company's current liquidity position and cash runway.
- Review the dilution effect on existing shareholders resulting from the issuance of shares from the ~8.33 million exercised warrants.
- Check subsequent filings for the allocation of these proceeds (e.g., debt repayment, R&D, or general corporate purposes).